(S (PP (IN In) (NP (DT the) (JJ pharmaceutical) (NN industry))) (NP (NP (DT the) (NN screening)) (PP (IN of) (NP (NP (JJ opaque) (NNS vaccines)) (VP (VBG containing) (NP (NNS suspensions)))))) (VP (VBZ is) (ADVP (RB currently)) (NP (NP (DT a) (JJ manual) (NN task)) (VP (VBD carried) (PRT (RP out)) (PP (IN by) (NP (JJ trained) (JJ human) (JJ visual) (NNS inspectors)))))) (. .))
(S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (JJ deep) (NN learning)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (ADVP (RB effectively)) (VB automate) (NP (DT this) (NN process))))))))))) (. .))
(S (NP (DT A) (VBG moving) (NN contrast)) (VP (VBZ is) (VP (VBN required) (S (VP (TO to) (VP (VB distinguish) (NP (NNS anomalies)) (PP (IN from) (NP (NP (NP (JJ other) (NNS particles)) (, ,) (NP (NNS reflections)) (CC and) (NX (NN dust))) (VP (NN resting) (PP (IN on) (NP (NP (DT a) (NN vial) (POS 's)) (NN surface))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP train) (S (NP (NNS 3D-ConvNets)) (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (NP (NP (JJ 20-frame) (NN video) (NNS samples)) (VP (VBG containing) (NP (NNS anomalies)))))))))) (. .))
(S (NP (PRP$ Our) (JJ unaugmented) (NN dataset)) (VP (VBZ consists) (PP (IN of) (NP (NP (JJ hand-labelled) (NNS samples)) (, ,) (VP (VBD recorded) (S (VP (VBG using) (NP (NP (NNS vials)) (VP (VBN provided) (PP (IN by) (NP (NP (DT the) (NNP HAL) (NNP Allergy) (NNP Group)) (, ,) (NP (DT a) (JJ pharmaceutical) (NN company)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD trained) (NP (RP ten) (ADJP (RB randomly) (VBN initialized)) (NNS 3D-ConvNets)) (S (VP (TO to) (VP (VB provide) (NP (DT a) (NN benchmark))))) (, ,) (S (VP (VBG observing) (NP (NP (JJ mean) (NNP AUROC) (NNS scores)) (PP (IN of) (NP (CD 0.94) (CC and) (CD 0.93))) (PP (IN for) (NP (NP (NP (JJ positive) (NNS samples)) (PRN (-LRB- -LRB-) (VP (VBG containing) (NP (NNS anomalies))) (-RRB- -RRB-))) (CC and) (NP (JJ negative) (PRN (-LRB- -LRB-) (JJ anomaly-free) (-RRB- -RRB-)) (NNS samples)) (, ,) (ADVP (RB respectively)))))))) (. .))
(S (S (VP (VBG Using) (NP (NNP Frame-Completion) (NNP Generative) (NNP Adversarial) (NNP Networks)))) (NP (PRP we)) (: :) (ADJP (PRN (-LRB- -LRB-) (NN i) (-RRB- -RRB-)) (VP (VBP introduce) (NP (NP (DT an) (NN algorithm)) (PP (IN for) (S (VP (VBG computing) (NP (NP (NN saliency) (NNS maps)) (, ,) (SBAR (WHNP (WDT which)) (S (NP (PRP we)) (VP (VBP use) (S (VP (TO to) (VP (VB verify) (SBAR (IN that) (S (NP (DT the) (NNS 3D-ConvNets)) (VP (VBP are) (ADVP (RB indeed)) (VP (JJ identifying) (NP (NNS anomalies))))))))))))))))))) (: ;) (VP (PRN (-LRB- -LRB-) (NN ii) (-RRB- -RRB-)) (VBD propose) (NP (NP (DT a) (JJ novel) (JJ self-training) (NN approach)) (VP (VBG using) (NP (DT the) (NN saliency) (NNS maps)) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (JJ multiple) (NNS networks)) (VP (VBP agree) (PP (IN on) (NP (NP (DT the) (NN location)) (PP (IN of) (NP (NNS anomalies)))))))))))))) (. .))
(S (NP (PRP$ Our) (JJ self-training) (NN approach)) (VP (VBZ allows) (S (NP (PRP us)) (VP (TO to) (VP (VB augment) (NP (PRP$ our) (NNS data) (VBN set)) (PP (IN by) (S (VP (VBG labelling) (NP (CD 217,888) (JJ additional) (NNS samples))))))))) (. .))
(S (NP (NP (NNS 3D-ConvNets)) (VP (VBN trained) (PP (IN with) (NP (PRP$ our) (JJ augmented) (NN dataset))))) (VP (VB improve) (PP (IN on) (NP (NP (DT the) (NNS results)) (SBAR (S (NP (PRP we)) (VP (VBP get) (SBAR (WHADVP (WRB when)) (S (NP (PRP we)) (VP (VBP train) (PP (ADVP (RB only)) (IN on) (NP (DT the) (JJ unaugmented) (NN dataset)))))))))))) (. .))
